Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Some potential reasons for not losing weight on Tirzepatide or any other treatment may include: Undiagnosed medical conditions Certain medical conditions, such as hormonal imbalances or thyroid disorders, can make it difficult to lose weight
Semaglutide (Ozempic / Wegovy) Targets the GLP-1 receptor only Weekly subcutaneous injection Clinical trials showed average weight loss of 15-17% of body weight FDA-approved for weight management (Wegovy) and type 2 diabetes (Ozempic) Tirzepatide (Mounjaro / Zepbound) Targets both GLP-1 and GIP receptors (dual agonist) Weekly subcutaneous injection Clinical trials showed average weight loss of 20-26% of body weight the highest of any medication FDA-approved for weight management (Zepbound) and type 2 diabetes (Mounjaro) The SURMOUNT-1 trial, published in the New England Journal of Medicine, demonstrated that tirzepatide at the highest dose (15mg) produced an average weight loss of 22.5% nearly one-quarter of body weight over 72 weeks
For tirzepatide dosing in units , check our conversion charts
With just a smartphone, tablet, or computer, you can converse with our proficient semaglutide providers
Collagen for Skin Whitening: Final Verdict There is no competition between these two supplements, as both of them work differently and offer varying benefits to the skin and overall health
Start by talking to your doctor about your weight loss goals, medical history, and any concerns
